Eliahu Gez

Duration of Androgen Suppression in the Treatment of Prostate Cancer

M. Bolla, Theodorus M. de Reijke, Geertjan van Tienhoven et al. · New England Journal of Medicine · 2009 · 952 citations · Full text

Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1–3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with <i>FGFR3</i> Alterations

Sumanta K. Pal, Jonathan E. Rosenberg, Jean Hoffman‐Censits et al. · Cancer Discovery · 2018 · 252 citations · Full text

Topical superoxide dismutase reduces post‐irradiation breast cancer fibrosis

F. Campana, Stefanos Zervoudis, B. Perdereau et al. · Journal of Cellular and Molecular Medicine · 2004 · 87 citations · Full text

Interstitial biodegradable balloon for reduced rectal dose during prostate radiotherapy: Results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study

Corinna Melchert, Eliahu Gez, G. Bohlen et al. · Radiotherapy and Oncology · 2013 · 59 citations

Adaptive Radiotherapy, Radiation Medicine, Medical Imaging +12

Concomitant and adjuvant androgen deprivation (ADT) with external beam irradiation (RT) for locally advanced prostate cancer: 6 months versus 3 years ADT—Results of the randomized EORTC Phase III trial 22961

M. Bolla, Geertjan van Tienhoven, Theodorus M. de Reijke et al. · Journal of Clinical Oncology · 2007 · 58 citations

Cancer Management, Adjuvant Androgen Deprivation, External Beam Irradiation +18